Australia markets closed

Connect Biopharma Holdings Limited (CNTB)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.4300-0.0200 (-1.38%)
At close: 04:00PM EDT
1.4200 -0.01 (-0.70%)
After hours: 04:06PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-59,503
-59,503
-118,091
-202,266
-119,270
Depreciation & amortisation
988
988
1,031
634
220.8685
Stock-based compensation
3,259
3,259
6,907
8,986
3,856
Change in working capital
9,485
9,485
6,459
3,579
-435.9206
Accounts payable
-4,277
-4,277
-776
8,966
283.1647
Other working capital
-48,224
-48,224
-105,925
-91,648
-27,928
Other non-cash items
-2,007
-2,007
-1,331
7
442.8084
Net cash provided by operating activities
-47,930
-47,930
-101,520
-84,324
-25,586
Cash flows from investing activities
Investments in property, plant and equipment
-294
-294
-4,405
-7,324
-2,342
Purchases of investments
-32,601
-32,601
-116,064
-17,959
-16,316
Sales/maturities of investments
105,191
105,191
34,226
20,076
19,108
Other investing activities
-84
-84
-
-
-
Net cash used for investing activities
75,155
75,155
-86,243
-5,207
448.7778
Cash flows from financing activities
Debt repayment
-290
-290
-222
-126
-82.3474
Common stock issued
44
44
18
219,985
0
Common stock repurchased
0
0
0
-566
0
Other financing activities
-
-
-
-17,107
140,710
Net cash used provided by (used for) financing activities
-246
-246
-85
202,220
140,627
Net change in cash
26,979
26,979
-187,848
112,689
115,490
Cash at beginning of period
79,010
79,010
267,716
154,803
47,292
Cash at end of period
106,007
106,007
79,010
267,716
154,604
Free cash flow
Operating cash flow
-47,930
-47,930
-101,520
-84,324
-25,586
Capital expenditure
-294
-294
-4,405
-7,324
-2,342
Free cash flow
-48,224
-48,224
-105,925
-91,648
-27,928